MetaCap

MannKind Balance Sheet

NASDAQ: MNKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.29-0.13 (-3.80%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

MannKind financial position

At the end of fiscal 2025, MannKind reported total assets of $792.2 million, up 101.1% from a year earlier against total liabilities of $843.2 million. Shareholders' equity was negative at -$51.0 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $74.9 million in cash and equivalents against $354.6 million of debt, a net debt position of $279.8 million.

The current ratio (current assets divided by current liabilities) was 1.70, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

MannKind balance sheet (annual)

MannKind annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31FY 20162016-12-31
Cash & Equivalents74.88M46.34M238.48M69.77M124.18M67.00M29.91M71.16M43.95M22.89M
Short-Term Investments96.46M150.92M56.62M101.08M79.93M019.98M———
Receivables38.37M11.80M14.90M16.80M4.74M4.22M3.51M4.02M2.79M302.00K
Inventory35.31M27.89M28.55M21.77M7.15M4.97M4.16M3.60M2.66M2.33M
Total Current Assets291.58M268.31M373.39M234.90M219.49M79.48M60.76M81.85M57.22M77.49M
Property, Plant & Equipment82.42M85.36M84.22M45.13M36.61M25.87M26.78M25.60M26.92M28.93M
Goodwill67.59M1.93M1.93M2.43M——————
Intangible Assets5.07M5.26M1.07M1.15M——————
Long-Term Investments5.01M5.48M7.16M1.96M56.62M—————
Total Assets792.18M393.84M475.20M295.28M321.16M108.61M93.72M107.70M84.58M107.06M
Accounts Payable9.03M6.79M9.58M11.05M6.96M5.58M4.79M5.38M6.98M3.26M
Short-Term Debt——————5.03M———
Total Current Liabilities171.03M81.84M104.13M67.30M48.35M73.70M65.62M75.24M87.60M92.05M
Long-Term Debt354.64M36.05M268.70M273.49M281.20M5.00M113.87M102.49M156.82M—
Total Liabilities843.20M472.66M721.37M545.82M530.51M289.03M284.25M282.79M299.31M290.66M
Shareholders' Equity-51.02M-78.82M-246.17M-250.54M-209.35M-180.42M-190.53M-175.08M-214.73M-183.59M
Retained Earnings-3.20B-3.20B-3.23B-3.22B-3.13B-3.05B-2.99B-2.94B-2.85B-2.74B
Total Debt354.64M36.05M268.70M273.49M281.20M5.00M118.90M102.49M156.82M—
Net Cash (Debt)-183.29M161.21M26.40M-102.64M-77.09M62.01M-69.02M-31.33M-112.88M22.89M
Shares Outstanding307.83M302.96M270.03M263.79M251.48M242.12M211.79M187.03M119.05M95.68M

This table shows 10 annual periods of MannKind's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MNKD's reporting calendar. What is a balance sheet?

More financial data